Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Gaithersburg, Maryland
- Most recent report
- 8-K/A, filed Aug 17, 2026
- Incorporated
- Delaware
- Filings on record
- 298 filings
- On EDGAR
- CIK 1757499
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 17
News 8 of 95
- 8-K/A Acquisition or disposal closed Aug 17, 2026
- 8-K Other events Jul 1, 2026
- 8-K Current report on a material event Jun 11, 2026
- 8-K Shareholder vote results May 27, 2026
- 8-K Leadership change May 7, 2026
- 8-K Significant contract May 1, 2026
- 8-K Significant contract Mar 10, 2026
- 8-K Quarterly results Feb 17, 2026
Prospectuses and Registrations 8 of 35
- 424B3 Prospectus supplement for an offering Mar 9, 2026
- S-1/A Registration statement for an offering, amended Feb 11, 2026
- S-1 Registration statement for an offering Feb 11, 2026
- 424B3 Prospectus supplement for an offering Feb 2, 2026
- S-1/A Registration statement for an offering, amended Dec 11, 2025
- S-1 Registration statement for an offering Nov 18, 2025
- 424B3 Prospectus supplement for an offering Aug 11, 2025
- S-1 Registration statement for an offering Aug 5, 2025
Proxies 8 of 14
- DEFA14A Extra proxy material Aug 13, 2026
- DEF 14A Proxy statement for a shareholder vote Aug 13, 2026
- PRE 14A Preliminary proxy statement Aug 3, 2026
- DEFA14A Extra proxy material May 12, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2026
- PRE 14A Preliminary proxy statement Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote May 6, 2025
- DEFR14A Apr 21, 2025
Ownership 8 of 62
- 4 Insider reported a trade Jul 15, 2026
- 4 Insider reported a trade Jul 13, 2026
- 3 Insider reported their initial holding Jul 13, 2026
- 4 Insider reported a trade Jul 9, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jul 1, 2026
- 3 Insider reported their initial holding Jul 1, 2026
Other 8 of 75
- NT 10-Q Notice that a quarterly report will be late Aug 17, 2026
- D May 15, 2026
- ARS Annual report sent to shareholders Apr 20, 2026
- EFFECT Notice that a registration became effective Feb 17, 2026
- CORRESP Reply to SEC staff Feb 13, 2026
- CORRESP Reply to SEC staff Feb 13, 2026
- EFFECT Notice that a registration became effective Jan 30, 2026
- CORRESP Reply to SEC staff Jan 29, 2026
Everything here comes from Shuttle Pharmaceuticals Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.